KEVIN CHARLES GORMAN
CIK 1201096 · Chief Executive Officer · last filed 2026-09-15
KEVIN CHARLES GORMAN is a Chief Executive Officer who has filed 104 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for NBIX, was dated Sep 15, 2026. Across all open-market trades the lifetime net is −$181.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $76.3M across reported positions. 95 SEC filings were submitted jointly with NEUROCRINE BIOSCIENCES INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$76.25M
2
104
-$181.45M
Filer Profile
SAN DIEGO, CA
Holdings By Company
Recent Filings
104 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-15 | NBIX | Mixed | +6,504 | -$1.22M | EDGAR |
| 2026-07-08 | XNCR | Grant (A) | +10,302 | $0 | EDGAR |
| 2026-06-17 | XNCR | Sell (S) | −7,527 | -$92.7K | EDGAR |
| 2026-06-15 | XNCR | Notice (144) | −7,527 | -$92.7K | EDGAR |
| 2026-05-29 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2026-05-21 | NBIX | Mixed | −40,000 | -$28.96M | EDGAR |
| 2026-05-19 | NBIX | Notice (144) | −245,088 | -$38.53M | EDGAR |
| 2026-02-17 | NBIX | Mixed | +34,400 | -$5.00M | EDGAR |
| 2026-02-03 | NBIX | Mixed | +2,297 | -$387.1K | EDGAR |
| 2025-08-11 | NBIX | Mixed | — | -$9.61M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.